Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
RNA-targeting CRISPR system
genome editing technology |
| gptkbp:alternativeName |
C2c2 system
|
| gptkbp:collateralActivity |
non-specific RNA cleavage
|
| gptkbp:component |
gptkb:Cas13_protein
gptkb:guide_RNA |
| gptkbp:discoveredBy |
gptkb:Feng_Zhang
|
| gptkbp:doesNotTarget |
gptkb:gene
|
| gptkbp:family |
gptkb:Class_2_Type_VI_CRISPR_system
|
| gptkbp:firstDescribed |
2016
|
| https://www.w3.org/2000/01/rdf-schema#label |
CRISPR-Cas13 system
|
| gptkbp:mechanismOfAction |
RNA-guided RNA cleavage
|
| gptkbp:origin |
gptkb:Bacteria
|
| gptkbp:patent |
gptkb:Broad_Institute
|
| gptkbp:relatedTo |
gptkb:CRISPR-Cas12_system
gptkb:CRISPR-Cas9_system |
| gptkbp:subspecies |
gptkb:Cas13a
gptkb:Cas13b gptkb:Cas13c gptkb:Cas13d |
| gptkbp:target |
gptkb:gene
|
| gptkbp:usedFor |
diagnostics
therapeutic applications gene regulation RNA editing RNA knockdown RNA virus detection live-cell RNA imaging antiviral defense |
| gptkbp:usedIn |
gptkb:SHERLOCK_diagnostic_platform
COVID-19 diagnostics |
| gptkbp:bfsParent |
gptkb:Cas_proteins
|
| gptkbp:bfsLayer |
7
|